Plasma extracellular vesicle tau, β-amyloid, and α-synuclein and the progression of Parkinson’s disease: a follow-up study

Plasma extracellular vesicle tau, β-amyloid, and α-synuclein and the progression of Parkinson’s disease: a follow-up study

Background: Plasma extracellular vesicle (EV) contents are promising biomarkers of Parkinson’s disease (PD). The pathognomonic proteins of PD, including α-synuclein, tau, and β-amyloid, are altered in people with PD (PwP) and are associated with clinical presentation in previous cross-sectional stud...

Full description

Bibliographic Details
Main Authors:	Lung Chan, Chen-Chih Chung, Yi-Chen Hsieh, Ruey-Meei Wu, Chien-Tai Hong
Format:	Article
Language:	English
Published:	SAGE Publishing 2023-01-01
Series:	Therapeutic Advances in Neurological Disorders
Online Access:	https://doi.org/10.1177/17562864221150329

Similar Items

Plasma Extracellular Vesicle α-Synuclein Level in Patients with Parkinson’s Disease
by: Chen-Chih Chung, et al.
Published: (2021-05-01)

The significance of α-Synuclein, Amyloid-β and Tau pathologies in Parkinson's disease progression and related dementia
by: Compta, Y, et al.
Published: (2013)

α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis
by: Pan Wang, et al.
Published: (2023-08-01)

Quantifying regional α ‐synuclein, amyloid β, and tau accumulation in lewy body dementia
by: Rebecca L. Miller, et al.
Published: (2022-02-01)

Neurofilament light chain level in plasma extracellular vesicles and Parkinson’s disease
by: Chen-Chih Chung, et al.
Published: (2020-12-01)

Altered Insulin Receptor Substrate 1 Phosphorylation in Blood Neuron-Derived Extracellular Vesicles From Patients With Parkinson’s Disease
by: Szu-Yi Chou, et al.
Published: (2020-12-01)

Plasma extracellular vesicle synaptic proteins as biomarkers of clinical progression in patients with Parkinson’s disease
by: Chien-Tai Hong, et al.
Published: (2024-03-01)

Cytokine Profile in Plasma Extracellular Vesicles of Parkinson’s Disease and the Association with Cognitive Function
by: Lung Chan, et al.
Published: (2021-03-01)

Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson’s Disease
by: Nai-Ching Chen, et al.
Published: (2020-04-01)

α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise
by: Simona Daniele, et al.
Published: (2018-01-01)

Parkinson’s Disease Dementia: Synergistic Effects of Alpha-Synuclein, Tau, Beta-Amyloid, and Iron
by: Jiajun Han, et al.
Published: (2021-10-01)

Oligomerization by co-assembly of β-amyloid and α-synuclein
by: Jin Ryoun Kim
Published: (2023-03-01)

The Mechanisms of the Roles of α-Synuclein, Amyloid-β, and Tau Protein in the Lewy Body Diseases: Pathogenesis, Early Detection, and Therapeutics
by: Moeko Noguchi-Shinohara, et al.
Published: (2023-06-01)

Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms
by: Mario Meloni, et al.
Published: (2023-01-01)

Alpha-Synuclein and Cognitive Decline in Parkinson Disease
by: Tian-Sin Fan, et al.
Published: (2021-11-01)

Direct Observation of α-Synuclein Amyloid Aggregates in Endocytic Vesicles of Neuroblastoma Cells.
by: Mihaela M Apetri, et al.
Published: (2016-01-01)

Neuronally derived extracellular vesicle α-synuclein as a serum biomarker for individuals at risk of developing Parkinson disease
by: Yan, S, et al.
Published: (2023)

Methodological considerations in neuronal extracellular vesicle isolation for α-synuclein biomarkers
by: Yan, S, et al.
Published: (2023)

Poly (ADP-Ribose) and α-synuclein extracellular vesicles in patients with Parkinson disease: A possible biomarker of disease severity.
by: Fabrice Lucien, et al.
Published: (2022-01-01)

Extracellular α-synuclein leads to microtubule destabilization via GSK-3β-dependent Tau phosphorylation in PC12 cells.
by: Magdalena Gąssowska, et al.
Published: (2014-01-01)

α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson’s Disease Patients and Correlate with Disease Severity
by: Simona Daniele, et al.
Published: (2018-02-01)

A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid.
by: Niels Kruse, et al.
Published: (2016-01-01)

Amyloid β,α-Synuclein and Amyloid β‑α-Synuclein Combination Exert Significant but Different Alterations in Inflammatory Response Profile in Differentiated Human SH-SY5Y Cells
by: Ebru Keskin, et al.
Published: (2023-11-01)

Differential role of CSF alpha-synuclein species, tau and Aβ42 in Parkinson’s Disease
by: Lucilla eParnetti, et al.
Published: (2014-03-01)

Amyloid-β and α-Synuclein Immunotherapy: From Experimental Studies to Clinical Trials
by: Jacqui Taryn Nimmo, et al.
Published: (2021-09-01)

A minute fraction of α-synuclein in extracellular vesicles may be a major contributor to α-synuclein spreading following autophagy inhibition
by: Hash Brown Taha, et al.
Published: (2022-09-01)

α-Synuclein increases β-amyloid secretion by promoting β-/γ-secretase processing of APP
by: Roberts, HL, et al.
Published: (2017)

α-Synuclein increases β-amyloid secretion by promoting β-/γ-secretase processing of APP.
by: Hazel L Roberts, et al.
Published: (2017-01-01)

Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-β and α-synuclein pathologies in the hippocampus of patients with Alzheimer’s disease and dementia with Lewy bodies
by: Sonja Fixemer, et al.
Published: (2022-03-01)

Propagation of Tau via Extracellular Vesicles
by: Mar Pérez, et al.
Published: (2019-07-01)

Meta-analysis to implement alpha-synuclein in extracellular vesicles as a potential biomarker for parkinson’s disease
by: Víctor H. Juárez-Vaquera, et al.
Published: (2023-10-01)

The Non-amyloidal Component Region of α-Synuclein Is Important for α-Synuclein Transport Within Axons
by: Eric N. Anderson, et al.
Published: (2020-01-01)

Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease
by: Mahsa Dolatshahi, et al.
Published: (2018-07-01)

Phosphorylated α-synuclein in diluted human serum as a biomarker for Parkinson's disease
by: Wei-Ru Chen, et al.
Published: (2022-12-01)

KIBRA regulates amyloid β metabolism by controlling extracellular vesicles secretion
by: Xiaolei Han, et al.
Published: (2022-04-01)

Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
by: Tingting Du, et al.
Published: (2021-03-01)

Plasminogen degrades α-synuclein, Tau and TDP-43 and decreases dopaminergic neurodegeneration in mouse models of Parkinson’s disease
by: Chunying Guo, et al.
Published: (2024-04-01)

Cell Responses to Extracellular α-Synuclein
by: Alexei A. Surguchev, et al.
Published: (2019-01-01)

Distinct Effects of Familial Parkinson’s Disease-Associated Mutations on α-Synuclein Phase Separation and Amyloid Aggregation
by: Bingkuan Xu, et al.
Published: (2023-04-01)

Role of α- and β-Synucleins in the Axonal Pathology of Parkinson’s Disease and Related Synucleinopathies
by: Akio Sekigawa, et al.
Published: (2015-05-01)